US Stock Movers On FDA Decision (AEZS, DCTH, VRUS, ALKS, ACOR, XOMA)

Æterna Zentaris Inc. (NASDAQ: AEZS) today announced that it will make an oral presentation, as well as a poster presentation on Erk/PI3K inhibitor compounds, Tuesday, April 20, at the American Association for Cancer Research (AACR) Annual Meeting, to be held April 17-21, 2010 at the Walter E. Washington Convention Center in Washington, D.C.

Subscribe to daily free stock newsletter by visiting:  http://www.PennyStockPickReport.com

Delcath Systems (NASDAQ:DCTH) announced this morning that an abstract for oral presentation was accepted at ASCO 2010 for June 5 at 430pm (ET) and the Company expects to report the pivotal Phase 3 study top-line results later this month.

Pharmasset, Inc. (NASDAQ: VRUS) announces the oral presentation of new sustained virologic response (SVR) follow-up data in hepatitis C virus (HCV) genotype 2 and 3 non-responder patients treated for 28 days with RG7128 in combination with the standard of care (SOC), Pegasys and Copegus, and presentation of an in vitro combination study with PSI-7977 and PSI-938.

Alkermes, Inc. (NASDAQ: ALKS) today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL (naltrexone for extended–release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence.

Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that four new analyses of clinical trial data on AMPYRA (dalfampridine) Extended Release Tablets 10 mg are being presented at the 62nd American Academy of Neurology (AAN) Annual meeting.

XOMA Ltd. (NASDAQ: XOMA) announced that the U.S. Patent and Trademark Office has issued two new patents that significantly expand the company's intellectual property portfolio relating to its anti-inflammatory antibody, XOMA 052, that targets interleukin-1 beta (IL-1 beta). One of the patents covers methods of treating Type 2 diabetes with high affinity antibodies and antibody fragments that bind to IL-1 beta, including XOMA 052.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks ,most active movers, top gainers, best penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.